The major efforts of this project are directed at developing novel diagnostic tools essential for controlling the spread of human immunodeficiency viruses (HIV-1 and HIV-2), by using various confirmatory supplemental tests.
The specific aim of this study is to develop a rapid and sensitive diagnostic assay for detection of HIV-1 in blood specimens. This project takes advantage of the body of knowledge obtained on HIV activation (Sadaie and Hager, Virol. 202: 513, 1994) and aims to establish a diagnostic assay based on virus activation. This approach can determine the level of latent proviral burden in peripheral blood lymphocytes (PBMCs) of HIV-1 infected individuals. Also, the level of reactivated viral RNA load in the PBMCs of HIV-1 infected """"""""long-term non-progressors"""""""" are currently studied.

Agency
National Institute of Health (NIH)
Institute
Food and Drug Administration (FDA)
Type
Intramural Research (Z01)
Project #
1Z01BP003014-01
Application #
5200832
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Bureau of Health Planning and Resources Development
Department
Type
DUNS #
City
State
Country
United States
Zip Code